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PHypertension
low-Mediated Vasodilation
nd the Risk of Developing
ypertension in Healthy Postmenopausal Women
osario Rossi, MD,* Emilio Chiurlia, MD,* Annachiara Nuzzo, MD,* Elena Cioni, MD,*
iorgia Origliani, PHD,† Maria Grazia Modena, MD, FESC, FACC*
odena, Italy
OBJECTIVES This study provided the opportunity to assess the relationship between endothelial vasomotor
function and incidence of hypertension in a cohort of postmenopausal women.
BACKGROUND Both menopause and hypertension are associated with endothelial dysfunction and are
well-known risk factors for atherosclerotic-related disease.
METHODS We conducted a prospective cohort study that began in 1996 on 952 apparently healthy
postmenopausal women, age 53  5 years (range 44 to 60 years), with initially normal levels
of blood pressure and no history of hypertension. All participants were followed up for a mean
period of 3.6  0.7 years (range 0.5 to 6.9 years). Endothelial function was measured as
flow-mediated dilation of the brachial artery using high-resolution ultrasound.
RESULTS During follow-up 112 women developed hypertension. The adjusted relative risk for women
with flow-mediated dilation of 3.5 or less (lowest quartile) was 5.77 (95% confidence interval
4.34 to 8.10) versus women with flow-mediated dilation of 5.5 or greater (highest quartile,
referent). Each one-unit decrease of flow-mediated dilation was associated with a significant
16% (95% confidence interval 12% to 33%) increase in the multiple-adjusted relative risk of
incident hypertension.
CONCLUSIONS These prospective data indicate a significant increase in the relative risk of hypertension with
each unit decrease of flow-mediated dilation that is independent of age and baseline systolic
and diastolic pressure values. This could suggest that an impaired endothelial vasomotor
function precedes and predicts the future development of hypertension in postmenopausal
women. (J Am Coll Cardiol 2004;44:1636–40) © 2004 by the American College of
ublished by Elsevier Inc. doi:10.1016/j.jacc.2004.07.027Cardiology Foundation
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Bardiovascular disease is the leading cause of death in
omen. Premenopausal women have significant reduced
isk of cardiovascular events compared with men of similar
ge, although the incidence of events increases greatly after
enopause (1). The postmenopause is a physiological con-
ition that is known to be associated with endothelial
ysfunction, due to a lack of estrogen, that is typical in this
hase of a woman’s life (2,3). There is considerable evidence
hat the impairment of endothelial function predicts the
evelopment of atherosclerosis (4).
In industrialized countries blood pressure (BP) increases
fter menopause in women such that the prevalence of
ypertension becomes higher in women than in men (5).
ndothelial dysfunction is common in hypertensive post-
enopausal women (6–10), and hypertension also increases
he incidence of atherosclerotic-related diseases (11,12).
Because endothelial dysfunction is also present in non-
ypertensive postmenopausal women (2,13), it is not clear
From the *Institute of Cardiology, University of Modena and Reggio Emilia,
odena, Italy; and †Bene Essere Donna Center, Azienda Universitaria-Ospedaliera
oliclinico, Modena, Italy. This study was partially supported by a grant from the
talian MURST (Ministero dell’Università e della Ricerca Scientifica e Tecnologica)
nd was sponsored by the WOCDA (WOmen’s Cardiovascular Disease Association).1
Manuscript received May 5, 2004; revised manuscript received June 26, 2004,
ccepted July 6, 2004.hether endothelial dysfunction is actually a consequence
r, rather, the cause of hypertension. This study provided
he opportunity to assess prospectively the association be-
ween endothelial function, evaluated by ultrasound, and the
ncidence of hypertension among apparently healthy, nor-
otensive postmenopausal women.
ETHODS
tudy overview and protocol. The patients enlisted in our
tudy were selected from women who had been referred to
he “Bene Essere Donna” center, an institution dedicated to
he study, prevention, and treatment of menopause-related
isorders. This service, located in a third-level university
ospital, is open to all women providing they are in their
ostmenopausal period (postmenopausal status was defined
s the absence of menstruation for at least 6 months and/or
y a follicle-stimulating hormone blood level 40 IU/l and
7 beta-estradiol levels 120 pmol/l) and are 60 years of
ge. These women, who are initially drawn to the center
hrough local media advertising, have free access and can
ake queries or obtain advice about particular symptoms
hey are having by fixing an appointment beforehand.
etween March 1, 1996, and July 31, 2003, we assessed
,682 women.
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October 19, 2004:1636–40 Endothelial Function and Incident HypertensionPhysical examination variables measured at baseline in-
luded body weight, height, waist circumference, and sys-
olic and diastolic BP. Blood pressure was measured by a
hysician with a mercury sphygmomanometer and cuff
dapted to arm circumference, with the subject sitting for at
east 10 min. The appearance of Korotkoff sounds was taken
o be the systolic, and their point of disappearance (phase V)
he diastolic BP. The average of three measurements was
onsidered for the analysis. Patient history, 12-lead electro-
ardiogram, and echocardiogram were used to exclude past
r present heart disease. At baseline each participant had
asting blood tests for levels of glucose, total cholesterol, and
riglycerides. Participants provided questionnaire data con-
erning lifestyle practices and potential risk factors for
ardiovascular disease. The exclusion criteria of the study
ere hypertension (BP 140/90 mm Hg or use of antihy-
ertensive medications), hyperlipidemia (total cholesterol
lasma levels 200 mg/dl and/or triglyceride levels 170
g/dl or use of hypolipemic drugs), smoking habits, history
f diabetes or use of hypoglycemic drugs or a fasting blood
lucose126 mg/dl, obesity (body mass index30 kg/m2),
istory of angina, previous myocardial infarction, previous
troke or transient ischemic attack, and previous or current
se of hormone replacement therapy.
A total of 952 healthy, normotensive postmenopausal
omen satisfied the criteria, with a mean age of 53  5
ears (range 44 to 60 years). The results were finally
laborated at the end of December 2003, when the last
omen to enroll had been followed for at least 0.5 years; the
ean follow-up was 3.6 0.7 years (range 0.5 to 6.9 years).
ll participants gave their written informed consent to
articipate in this study, which had been approved by the
cience and ethics committee of our institution.
ltrasound studies of the brachial artery. An ultrasound
tudy of the brachial artery was performed in all participants
t baseline by means of an Acuson 128 XP/10 mainframe
Acuson, Mountain View, California) with a 7.0-MHz
inear array transducer. Images were stored on a Super VHS
ideotape recorder for further analysis.
The technique for assessing brachial artery flow-mediated
ilation (FMD) has been described in detail elsewhere
14,15). Briefly, FMD was assessed in the subject’s right
rm in the recumbent position after a 15-min equilibration
eriod in a temperature-controlled room (22°C to 25°C).
ach subject had fasted the previous night for at least 12 h.
Abbreviations and Acronyms
AII  angiotensin II
AT2  angiotensin type 2 receptors
BAD  brachial artery diameter
BP  blood pressure
FMD  flow-mediated dilation
NO  nitric oxide
PAI-1  plasminogen activator inhibitor 1he artery was longitudinally imaged approximately 5 cm croximal to the antecubital crease, and brachial artery
iameter (BAD) was measured at end-diastole. After the
aseline resting scan, a pneumatic cuff placed at the level of
he mid-forearm (proximal to the target artery) was inflated
ntil no blood flow was detected through the brachial artery
ith the Doppler probe, and this pressure was held for 5
in. Increased flow was then induced with sudden cuff
eflation and a continuous scan was performed for 1 min.
or the reactive hyperemia scan, BAD measurements were
aken 45 to 60 s after cuff deflation. Flow-mediated dilation
as calculated from the diameters as (reactive hyperemia 
aseline)/baseline percent.
To evaluate the reproducibility of echographic measure-
ents, 100 studies were reexamined by two different inves-
igators (M.G.M. and R.R.). These exams were selected at
andom, without knowledge of the patient’s identity, clinical
nformation, or previous evaluation results. The interob-
erver variability for percent of FMD resulted in 0.10 
.69%.
efinition and ascertainment of cases. All women were
een in our outpatient clinic at regular interval (every six
onths). Telephone contact was used every three months to
educe the dropout rate. At baseline and at every six-month
ollow-up visit women underwent an interview, examina-
ion, and BP measurements. New cases of hypertension
ere identified in the following ways: 1) self-reported use of
ntihypertensive medications; 2) self-report of physician
iagnosis; 3) comparison of systolic BP values 140 mm
g and/or diastolic BP values90 mm Hg during the visit.
f this latter condition was encountered, we took steps to
heck the BP, before diagnosing hypertension, on two
urther occasions: the first after one week and the second
fter one month from the initial anomalous measurement.
nly in cases where these values remained persistently high
140 mm Hg for systolic BP and/or 90 mm Hg for
iastolic BP) was hypertension diagnosed. For individuals
lassified by physician diagnosis or medication use, date of
ypertension onset was considered to be the midpoint
etween the last visit when a woman was not hypertensive
nd the first visit when a woman was hypertensive. For
hose diagnosed through the serial measurement of BP
alues, the onset date of hypertension was considered to be
hat when hypertension was first encountered. All hyper-
ensive patients were then contacted by telephone to avoid
he possibility that a false diagnosis of hypertension could
nvalidate the results of the study.
tatistical analyses. Continuous variables are presented as
ean values  1 SD, and categorical variables as percent-
ges. Differences in baseline characteristics between groups
ere examined by analysis of variance and the chi-square
est when appropriate. We used a Cox proportional hazards
egression model to analyze the association between endo-
helial function and incident hypertension. Person-time was
alculated from enrollment until the date of hypertension
nset, death, dropout, or the study’s end, whichever oc-
urred first. The percent of FMD was evaluated in two
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ested both the proportional hazard and linearity assump-
ions of the association between percent of FMD and
ypertension and found no violations. We computed crude,
ge-adjusted, baseline systolic and diastolic BP-adjusted,
nd multiple-adjusted hazard ratios (and 95% confidence
ntervals) as a measure of the relative risks of incident
ypertension for decreasing percent of FMD, with the
ighest quartile as the referent. We used an ordinal variable
the median value of percent of FMD in each quartile) to
est for trend in risk across FMD quartiles, using the
antel-Haenzsel extension test (16,17). Adjusted estimates
f risk were calculated by the multiple regression model,
hich controlled for a range of potential confounders
elected a priori, including age (continuous), family history
f hypertension (yes/no), baseline values of systolic and
iastolic BP (continuous), body mass index (continuous),
aist circumference (continuous), duration of postmeno-
ausal period (continuous), years of education (continuous),
lcohol consumption (never,1 drink per day, 2 to 6 drinks
er week, 1 to 5 drinks per month), and physical activity
never, 1 to 2 times per week, 3 times per week).
wo-tailed p values 0.05 were considered significant.
ESULTS
uring 3.6  0.7 years (3,432 person-years) of follow-up,
able 1. Baseline Characteristics of the Study Participants, Accor
4° Quar
evels of FMD, % 5.5
MD (median), % 6.2
AD, mm 4.01 
emographic, anthropometric, and clinical parameters
ge, yrs 54 
MI, kg/m2 25.9 
aist circumference, % 84 
aucasian, % 100 (n
ducation, yrs 14 
iving in urban areas, % 79.8 (n 
istory of hypertension, % 25.2 (n
ystolic BP, mm Hg 124 
iastolic BP, mm Hg 82 
eart rate, beats/min 72 
ime from menopause, months 45 
xercise, times/week
Never, % 46.2 (n
1–2, % 39.6 (n
3, % 14.2 (n
lcohol consumption
Never, % 11.7 (n
1 drink per day, % 3.9 (n 
2–6 drinks per week, % 47.0 (n 
1–5 drinks per month, % 37.4 (n 
iochemical profile
Total cholesterol, mg/dl 189 
Triglycerides, mg/dl 146 
Glucose, mg/dl 86 
ata are expressed as mean  1 SD or as a percentage. Results of all comparisons w
BAD  brachial artery diameter; BMI  body mass index; BP  blood pressure12 incident cases of hypertension occurred. Of these, 58 of o12 (51.8%) were diagnosed by personal physician, 41 of
12 (36.6%) were diagnosed at our clinic, and 13 patients
11.6%) stated that they were taking antihypertensive drugs.
ll hypertensive patients were contacted by telephone be-
ween March 15 and 31, 2004. All of these patients were
aking at least one antihypertensive medication, and 84 of
hem (75%) were following a therapy involving at least two
uch drugs.
During follow-up three patients died, all of non-cardiac
elated causes (one accident and two neoplasm), and we lost
ontact with 4 patients, making a total of 7 out of 952
atients (0.007%).
Table 1 gives the baseline characteristics of the partici-
ants, according to percent of FMD quartiles. There were
o significant differences between groups regarding all
nvestigated parameters.
The relative risks of hypertension according to percent of
MD quartiles are summarized in Table 2. The relative risk
ecreased steadily across percent of FMD categories com-
ared with the referent quartile (FMD  5.5%) (Fig. 1).
djustment for age, baseline BP values, and various con-
ounders attenuated the relative risk only slightly.
When percent of FMD was examined as a continuous
ariable, each one-unit decrease of percent of FMD was
ssociated with a significant 16% (95% confidence interval
2% to 33%) increase in the multiple-adjusted relative risk
to the Quartiles of Flow-Mediated Dilation
3° Quartile 2° Quartile 1° Quartile
4.3–5.4 3.6–4.2 3.5
4.9 3.8 3.1
3.99  0.57 3.97  0.58 3.98  0.60
52  6 52  4 54  6
26.1  3.0 26.2  2.8 26.0  2.9
82  13 80  16 81  14
100 (n 238) 100 (n 238) 100 (n 238)
13  4 13  5 13  5
78.9 (n 188) 80.6 (n 192) 76.9 (n 183)
27.3 (n 65) 24.3 (n 58) 23.1 (n 55)
128  112 125  13 126  13
83  7 83  8 82  7
73  9 75  7 70  9
32  11 33  10 44  12
47.0 (n 112) 48.3 (n 115) 47.8 (n 114)
40.9 (n 97) 37.5 (n 89) 43.0 (n 102)
12.1 (n 29) 14.2 (n 34) 9.2 (n 22)
10.1 (n 24) 13.8 (n 33) 14.7 (n 35)
3.4 (n 8) 5.2 (n 12) 4.3 (n 10)
49.1 (n 117) 48.3 (n 115) 49.5 (n 118)
37.4 (n 89) 32.7 (n 78) 31.5 (n 75)
185  15 190  17 188  19
150  15 148  19 154  16
87  8 87  7 85  8
on-significant.
 flow-mediated dilation.ding
tile
0.56
5
3.1
13
238)
3
190)
60)
14
8
10
10
110)
94)
34)
28)
9)
112)
89)
17
17
9f incident hypertension.
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ur study demonstrates that in healthy, normotensive
ostmenopausal women, endothelial-dependent vasodila-
ion is a parameter able to significantly predict the future
evelopment of hypertension independently of age, baseline
P, and numerous other well-known risk factors. In our
pinion, this ability is very important because it radically
hanges the way of considering endothelial dysfunction. We
re used to explaining endothelial dysfunction as a conse-
uence of the endothelium’s exposure to damaging factors:
igh BP levels, high lipid concentrations, high blood glu-
ose levels, smoking, and so on (response-to-injury theory).
ur data radically overturn the problem because they
uggest that endothelial dysfunction may be the cause (or at
east a significant cause) of the development of hyperten-
ion.
Although our data support etiological associations, at this
ime explicit mechanisms remain speculative and require
urther study. Some hypotheses for our results warrant
urther discussion. First, it is well known that percent of
able 2. Crude, Age-, Baseline Systolic and Diastolic Blood Pres
ypertension by Quartiles of Flow-Mediated Dilation
4° Quar
(Referen
evels of FMD, % 5.5
ncident hypertension (no. of cases) person-yrs 9
862
ncidence rate (no. of cases per 1,000 person-yrs) 10.4
elative risk, crude (95% CI) 1.00
elative risk, age-adjusted (95% CI) 1.00
elative risk, baseline SBP and DBP-adjusted (95% CI) 1.00
elative risk, multiple†-adjusted (95% CI) 1.00
p  0.0001 test for linear trend. †Multiple regression model adjusted for age (conti
continuous), body mass index (continuous), waist circumference (continuous), du
onsumption (never,  1 drink per day, 2–6 drinks per week, 1–5 drinks per month
CI  confidence interval; DBP  diastolic blood pressure; FMD  flow-mediat
igure 1. Relative risk of developing hypertension in relation to the
ercent of flow-mediated dilation (FMD) quartiles. The fourth quartile
ust be considered as the referent one. p  0.0001 for trend. Numbers inv
he bars represent the incidence rate (new cases of hypertension per 1,000
erson-years). Q  quartile.MD induced by reactive hyperemia is endothelium-
ependent (18,19); in other words, it depends on the ability
f endothelium to produce vasodilator-endowed substances,
ainly nitric oxide (NO). It is well demonstrated that
ostmenopausal status is associated with significant reduced
rterial NO activity (20). It is reasonable that our patients
ith a lower level of percent of FMD had a higher degree
f endothelial dysfunction, essentially meaning a lower
roduction of NO. There are numerous reports on the fact
hat a chronic inhibition in the production of NO is able to
ause an increase in peripheral resistance, an impaired renal
bility to excrete sodium (all mechanisms that contribute in
ncreasing BP), and progressive renal damage in experimen-
al hypertension (21–23). Even in humans, a gradual inhi-
ition in the production of NO is associated with an
ncrease in arterial resistance (24). Furthermore, an impor-
ant correlation between endothelial dysfunction and the
evelopment of hypertension is mediated by angiotensin II
AII). It is well known that in postmenopausal women
lasma renin activity and the consequent production of AII
s significantly higher with respect to the premenopausal
eriod (25). Angiotensin II, through type 2 angiotensin
eceptors (AT2), leads to vasodilation. It is also known that
II vasodilatory action is controlled by the NO produced by
he endothelium (26). It is therefore reasonable to assume
hat a normal endothelial function, with a consequent
ormal production of NO, plays a highly limiting role in the
evelopment of hypertension.
Another consequence of endothelial dysfunction is the
ncreased production of prothrombotic activity substances,
he most important of which being plasminogen activator
nhibitor 1 (PAI-1). Fibrinolytic activity is in fact primarily
ediated by the balance between the levels of tissue plas-
inogen activator and PAI-1, both of which are synthe-
ized by the endothelium (27). Therefore, endothelium
njury induces an imbalance in fibrinolysis (28,29). So it is
easonable to assume that in case of endothelial dysfunction
he production of PAI-1 increases even in postmenopausal
omen. It is known that hypertensive patients have PAI-1
Values-, and Multiple-Adjusted Relative Risk of Incident
3° Quartile 2° Quartile 1° Quartile
4.3–5.4 3.6–4.2 3.5
19 35 49
910 858 802
20.9 40.8 61.1
2.01 (1.77–3.54) 3.92 (2.85–5.21) 5.87* (4.88–9.06)
1.97 (1.70–3.48) 3.39 (2.78–4.90) 5.86* (4.31–8.12)
1.95 (1.80–3.55) 3.56 (2.90–5.11) 5.80* (4.30–7.88)
1.92 (1.62–3.55) 3.00 (2.43–4.29) 5.77* (4.34–8.10)
, family history of hypertension (yes/no), baseline values of systolic and diastolic BP
of postmenopausal period (continuous), years of education (continuous), alcohol
physical activity (never, 1–2 times per week,  3 times per week).
ation; SBP  systolic blood pressure.sure
tile
t)
nuous)
rationalues that are notably higher with respect to normotensive
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osis and hypertension is so tight that in Framingham’s
ohort a significant correlation between BP values and
AI-1 levels was clearly demonstrated (32).
imits of the study. Our study has several strengths,
ncluding the prospective design, the large sample of exam-
ned women, the relatively homogeneous nature of the
ohort, and the ability to exactly determine the time of
nrollment and hypertension onset.
The most important limit of the study is that it is a
on-randomized, strictly observational study that shows an
nteresting association between percent of FMD and risk of
eveloping hypertension, which may indicate that some
s-yet-undiscovered pathophysiological alteration drives
oth processes or may be causal. For these reasons our
ndings should be viewed with caution. Another limiting
actor to our study was the fact that all participants were
elatively young and free from cardiovascular risk factors and
ardiac pathologies. The results we obtained, therefore, are
pplicable only to a limited number of postmenopausal
omen, not to all; nor, for that matter, are they applicable
o men.
linical implications. The perspectives of these data may
e of great clinical impact. Locating an impaired percent of
MD permits us to recognize those patients that are at high
isk for the development of hypertension. Such patients
hould therefore be persuaded to alter their lifestyle with the
im of reducing this risk. A close follow-up and aggressive
anagement of other known cardiovascular risk factors
ould be justified in these subjects.
eprint requests and correspondence: Dr. Rosario Rossi, Insti-
ute of Cardiology, University of Modena and Reggio Emilia,
oliclinico, Via del Pozzo, 71, 41100 Modena, Italy. E-mail:
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